Technical analysis of Bionano Genomics, Inc. (BNGO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles.
Price Performance
| 1 month | +27.97% |
| 3 months | +32.46% |
| Year-to-date | -1.31% |
| 1 year | -14.69% |
| 3 years | -99.16% |
52-Week Range
| 52-week High | $2.23 |
| 52-week Low | $1.00 |
| Avg Volume (90d) | 610K |
Technical Indicators
| SMA 50 | $1.18 |
| SMA 200 | $1.27 |
| 30-day Volatility (annualised) | 64.0% |
| Price vs SMA 50 | +27.6% |
| Price vs SMA 200 | +19.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.80 | |
| 2025-11 | $1.85 | +2.8% |
| 2025-12 | $1.53 | -17.3% |
| 2026-01 | $1.30 | -15.0% |
| 2026-02 | $1.15 | -11.5% |
| 2026-03 | $1.17 | +1.7% |
| 2026-04 | $1.16 | -0.9% |
| 2026-05 | $1.24 | +6.9% |
| 2026-06 | $1.13 | -8.9% |
| 2026-07 | $1.07 | -5.3% |
| 2026-08 | $1.22 | +14.0% |
| 2026-09 | $1.51 | +23.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | | |
| 2026-09-15 | $0.14 | $2.28B |
| 2026-09-15 | | |
Price
| Price | $1.51 |
| Market Cap | $17M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.54 |
| EV / EBITDA | -0.75 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.21 |
| Current Ratio | 2.48 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -14.26 |